Skip to main content
. 2017 Sep 1;109(12):djx098. doi: 10.1093/jnci/djx098

Table 1.

Characteristics of breast cancer patients in relation to CTCAE neuropathy grade (n = 1225) and neuropathy score as determined by the FACT/GOG-Ntx (n = 922)

Characteristic CTCAE neuropathy grade score
FACT/GOG-Ntx score tertiles
3–4 No. (%) 0–2 No. (%) P* 3 No. (%) 2 No. (%) 1 No. (%) P*
Total, No. (%) 152 (12.4) 1073 (87.6) -- 321 (34.8) 320 (34.7) 281 (30.5) --
Age, y .05 .001
 <40 37 (9.4) 358 (90.6) 17 (17.2) 39 (39.4) 43 (43.4)
 40–49 60 (14.0) 368 (86.0) 93 (32.4) 98 (34.1) 96 (33.4)
 50–59 41 (15.7) 220 (84.3) 128 (38.7) 113 (34.1) 90 (27.2)
 ≥60 14 (9.9) 127 (90.1) 83 (40.5) 70 (34.1) 52 (25.4)
Race/ethnicity .007 .12
 Non-Hispanic white 110 (11.2) 874 (88.8) 251 (33.2) 268 (35.4) 237 (31.3)
 Hispanic 5 (8.8) 52 (91.2) 18 (54.5) 5 (15.2) 10 (30.3)
 Black/African American 17 (20.5) 66 (79.5) 22 (37.3) 22 (37.3) 15 (25.4)
 Other 20 (19.8) 81 (80.2) 30 (40.5) 25 (33.8) 19 (25.7)
Body mass index, kg/m2 .21 <.001
 Underweight (≤18.5) 0 (0) 11 (100) 2 (28.6) 3 (42.9) 2 (28.6)
 Normal (18.5–24.9) 36 (10.5) 308 (89.5) 72 (26.9) 81 (30.2) 115 (42.9)
 Overweight (25–29.9) 68 (14.4) 403 (85.6) 142 (41.0) 125 (36.1) 79 (22.8)
 Obese (≥30) 47 (12.2) 337 (87.8) 105 (36.0) 106 (36.3) 81 (27.7)
Menopausal status, No. .02
 Premenopausal 57 (10.1) 510 (89.9) 124 (29.7) 145 (34.8) 148 (35.5)
 Postmenopausal 95 (14.4) 563 (85.6) 197 (39.0) 175 (34.7) 133 (26.3)
Smoking history .90 .02
 Never smoker 80 (12.0) 584 (88.0) 158 (30.9) 184 (35.9) 170 (33.2)
 Former smoker 51 (12.8) 347 (87.2) 111 (37.4) 103 (34.7) 83 (27.9)
 Current smoker 20 (13.2) 132 (86.8) 50 (46.3) 50 (46.3) 27 (25.0)
Education .07 .02
 < High school graduate 18 (20.5) 70 (79.5) 23 (41.1) 12 (21.4) 21 (37.5)
 High school graduate or GED 33 (12.6) 228 (87.4) 72 (36.5) 74 (37.6) 51 (25.9)
 Some college 56 (12.9) 377 (87.1) 130 (39.5) 104 (31.6) 95 (28.9)
 College graduate 23 (8.7) 242 (91.3) 63 (31.0) 71 (35.0) 69 (34.0)
 Advanced degree 22 (12.7) 151 (87.3) 33 (24.6) 57 (32.8) 44 (32.8)
Marital status .11 .14
 Married or living as married 105 (11.8) 786 (88.2) 234 (33.7) 231 (33.3) 229 (33.0)
 Widowed 12 (21.1) 5 (78.9) 12 (31.6) 15 (39.5) 11 (28.9)
 Separated or divorced 29 (14.5) 171 (85.5) 55 (40.7) 53 (39.3) 27 (20.0)
 Single 6 (8.5) 65 (91.5) 18 (35.3) 19 (37.3) 14 (27.5)
Physical activity† .82 .19
 No 28 (12.0) 206 (88.0) 69 (40.8) 54 (32.0) 46 (27.2)
 Yes 124 (12.5) 867 (87.5) 252 (33.5) 266 (35.3) 235 (31.2)
Treatment arm‡ .003 .25
 1 39 (16.0) 205 (84.0) 77 (40.1) 66 (34.4) 49 (25.5)
 2 36 (16.6) 181 (83.4) 58 (34.7) 59 (35.3) 50 (29.9)
 3 21 (8.1) 238 (91.9) 73 (36.7) 59 (29.6) 67 (33.7)
 4 19 (8.0) 218 (92.0) 52 (30.4) 66 (38.6) 53 (31.0)
 5 21 (17.6) 98 (82.4) 25 (29.1) 38 (44.2) 23 (26.7)
 6 16 (10.7) 133 (89.3) 36 (33.6) 32 (29.9) 39 (36.4)
CTCAE grade <.001
 0–2 243 (30.3) 290 (36.1) 270 (33.6)
 3–4 78 (65.5) 30 (25.2) 11 (9.2)
*

P values were computed using two-sided chi-square tests. CTCAE = Common Terminology Criteria for Adverse Events; FACT/GOG-Ntx = Functional Assessment of Cancer Therapy/Gynecologic Oncology Group Neurotoxicity.

In month before diagnosis.

Treatment arms correspond to the descriptions given in Figure 1.